Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Pulpa Dentis D30 for Acute Reversible Pulpifis: A Prospective Cohort Study in Routine Dental Practice.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Subject Terms:
- Subject Terms:
- Abstract:
Background • Pulpa dentis D30 (PD: dental pulp of the calf, prepared in a homeopathic D30 potency) has been used in acute reversible pulpitis for pain relief and to avoid or postpone invasive dental treatment. Primary Study Objective • To study short-term clinical outcomes of PD therapy for acute reversible pulpitis in routine dental practice. Methods/Design • Prospective, observational, open-label, single-arm cohort study. Setting • Eleven dental primary care practices in Germany. Participants and Intervention • Thirty-two patients starting monotherapy with PD for acute reversible pulpitis without visible or radiological abnormalities. PD was applied as 1-mL submucous injections into the mucobuccal fold, repeated daily as needed. Primary Outcome Measures • Avoidance of invasive dental treatment (pulp capping, root canal therapy, tooth extraction) and remission of pain, measured on a 0-10 point scale (partial remission: reduction by ≥3 points; complete remission: reduction from ≥4 points to 0-1 points) during the 10-day follow-up period. Results • Median pain duration was 14.0 days. The patients received a median of two PD applications (range 1-7). A total of 81% (n=26/32) of patients did not require invasive dental treatment, and 19% (n = 6) had root canal therapy. Remission status was evaluable in 24 patients. Of these, 63% (n = 15/24) achieved pain remission, 58% (n = 14) remitted without invasive dental treatment (complete remission: n = 12, partial remission: n = 2), and 29% (n = 7) had a close temporal relationship between PD and remission (ratio "time to remission after first PD application vs pain duration prior to first PD application" <1:10). Conclusion • In this study of PD for acute reversible pulpitis, 58% of evaluable patients achieved pain remission without invasive dental treatment. The open-label pre-post design does not allow for conclusions about comparative effectiveness. However, more than one-fourth of evaluable patients remitted with a close temporal relationship between the first PD application and pain remission, suggesting a causal relationship between therapy and remission. [ABSTRACT FROM AUTHOR]
No Comments.